The Food and Drug Administration Generally Spent Prescription Drug User Fee Collections Appropriately

The Food and Drug Administration (FDA) generally spent prescription drug user fee collections appropriately. However, FDA did not have adequate supporting documentation for $6,403 in travel expenses, made a duplicate payment for airfare of $1,213, and overpaid a traveler $587. FDA recovered the duplicate payment and overpayment from the travelers during our review. The lack of supporting documentation appeared to be an oversight by FDA staff and not a systemic issue. Accordingly, this report contains no recommendations.